Kestra Medical Technologies' (NASDAQ:KMTS - Get Free Report) quiet period is set to expire on Tuesday, April 15th. Kestra Medical Technologies had issued 11,882,352 shares in its IPO on March 6th. The total size of the offering was $201,999,984 based on an initial share price of $17.00. During Kestra Medical Technologies' quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
Wall Street Analysts Forecast Growth
KMTS has been the topic of several research analyst reports. Wells Fargo & Company began coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They issued an "overweight" rating and a $28.00 price objective on the stock. Piper Sandler began coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set an "overweight" rating and a $27.00 target price on the stock. Stifel Nicolaus began coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They issued a "buy" rating and a $28.00 price objective for the company. The Goldman Sachs Group assumed coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They issued a "neutral" rating and a $24.00 target price for the company. Finally, Bank of America began coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They issued a "buy" rating and a $30.00 price objective for the company. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $27.67.
View Our Latest Analysis on KMTS
Kestra Medical Technologies Stock Up 0.3 %
Shares of KMTS traded up $0.08 during trading hours on Friday, hitting $24.28. The stock had a trading volume of 355,900 shares, compared to its average volume of 278,008. Kestra Medical Technologies has a 52 week low of $20.00 and a 52 week high of $26.06.
Kestra Medical Technologies Company Profile
(
Get Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Recommended Stories
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
